 Elaine Reno
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Travel | 3 | 2023 | 130 | 1.380 |
Why?
| | Altitude Sickness | 3 | 2019 | 153 | 1.160 |
Why?
| | Toxoplasmosis | 1 | 2023 | 40 | 0.840 |
Why?
| | Toxoplasma | 1 | 2023 | 42 | 0.840 |
Why?
| | Sunlight | 1 | 2022 | 73 | 0.760 |
Why?
| | Water Purification | 1 | 2022 | 152 | 0.680 |
Why?
| | Yellow Fever | 1 | 2020 | 8 | 0.670 |
Why?
| | Altitude | 3 | 2022 | 488 | 0.640 |
Why?
| | Massive Hepatic Necrosis | 1 | 2019 | 3 | 0.630 |
Why?
| | Hepatitis A | 1 | 2019 | 26 | 0.620 |
Why?
| | Radiology | 1 | 2021 | 180 | 0.610 |
Why?
| | Social Media | 1 | 2021 | 158 | 0.590 |
Why?
| | Endometrial Neoplasms | 3 | 2009 | 201 | 0.560 |
Why?
| | Students, Medical | 1 | 2021 | 348 | 0.520 |
Why?
| | Telemedicine | 2 | 2022 | 862 | 0.470 |
Why?
| | Mental Disorders | 1 | 2023 | 1077 | 0.460 |
Why?
| | Hypoxia | 1 | 2019 | 1112 | 0.370 |
Why?
| | Protein Kinase C-delta | 2 | 2009 | 48 | 0.350 |
Why?
| | Suicide | 1 | 2017 | 656 | 0.330 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 162 | 0.300 |
Why?
| | Depression | 1 | 2017 | 1397 | 0.290 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1910 | 0.280 |
Why?
| | Extreme Environments | 1 | 2024 | 4 | 0.220 |
Why?
| | Wilderness Medicine | 1 | 2024 | 11 | 0.220 |
Why?
| | Adenocarcinoma | 2 | 2009 | 940 | 0.220 |
Why?
| | Antibodies, Protozoan | 1 | 2023 | 36 | 0.210 |
Why?
| | Apoptosis | 3 | 2009 | 2553 | 0.210 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 165 | 0.210 |
Why?
| | Travel-Related Illness | 1 | 2023 | 5 | 0.200 |
Why?
| | Plastics | 1 | 2022 | 42 | 0.200 |
Why?
| | Water Microbiology | 1 | 2022 | 85 | 0.190 |
Why?
| | Immunoglobulin M | 1 | 2023 | 289 | 0.190 |
Why?
| | Propensity Score | 1 | 2023 | 294 | 0.190 |
Why?
| | Disinfection | 1 | 2022 | 124 | 0.180 |
Why?
| | Yellow Fever Vaccine | 1 | 2020 | 6 | 0.170 |
Why?
| | Africa | 1 | 2020 | 108 | 0.160 |
Why?
| | Latin America | 1 | 2020 | 93 | 0.160 |
Why?
| | Immunization, Secondary | 1 | 2020 | 87 | 0.160 |
Why?
| | Humans | 15 | 2024 | 137585 | 0.160 |
Why?
| | Peru | 1 | 2019 | 58 | 0.160 |
Why?
| | Environmental Exposure | 1 | 2024 | 579 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2023 | 893 | 0.160 |
Why?
| | Radiography | 1 | 2021 | 822 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2024 | 527 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2022 | 512 | 0.150 |
Why?
| | Fatal Outcome | 1 | 2019 | 303 | 0.150 |
Why?
| | Escherichia coli | 1 | 2022 | 815 | 0.150 |
Why?
| | Drug Utilization | 1 | 2018 | 169 | 0.140 |
Why?
| | Exercise Tolerance | 1 | 2019 | 279 | 0.130 |
Why?
| | Sinusitis | 1 | 2018 | 221 | 0.120 |
Why?
| | Headache | 1 | 2016 | 147 | 0.120 |
Why?
| | Migraine Disorders | 1 | 2016 | 102 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1483 | 0.110 |
Why?
| | Oxygen | 1 | 2019 | 931 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2018 | 546 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.100 |
Why?
| | Female | 10 | 2024 | 73304 | 0.090 |
Why?
| | Middle Aged | 4 | 2019 | 33479 | 0.090 |
Why?
| | Male | 5 | 2023 | 67762 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2828 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2069 | 0.080 |
Why?
| | Protein Kinase C-alpha | 1 | 2009 | 37 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2009 | 103 | 0.080 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 144 | 0.080 |
Why?
| | Etoposide | 1 | 2009 | 158 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2691 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 171 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 327 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 283 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1809 | 0.070 |
Why?
| | Phosphorylation | 2 | 2009 | 1759 | 0.070 |
Why?
| | Leiomyoma | 1 | 2008 | 77 | 0.070 |
Why?
| | Risk Factors | 2 | 2019 | 10388 | 0.070 |
Why?
| | Enzyme Activation | 1 | 2009 | 810 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 124 | 0.070 |
Why?
| | Uterine Neoplasms | 1 | 2008 | 109 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2022 | 15657 | 0.060 |
Why?
| | DNA Damage | 1 | 2009 | 420 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 396 | 0.060 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 955 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2007 | 620 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2009 | 2475 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1738 | 0.050 |
Why?
| | Wilderness | 1 | 2023 | 16 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 916 | 0.050 |
Why?
| | Nausea | 1 | 2023 | 111 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 130 | 0.050 |
Why?
| | United States | 1 | 2019 | 14841 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 3412 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1774 | 0.040 |
Why?
| | Pregnancy | 2 | 2024 | 6763 | 0.040 |
Why?
| | Signal Transduction | 1 | 2009 | 5079 | 0.030 |
Why?
| | Mice | 2 | 2009 | 17787 | 0.030 |
Why?
| | Acute Disease | 1 | 2016 | 1007 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 2071 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2074 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3295 | 0.020 |
Why?
| | Animals | 2 | 2009 | 36940 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 91 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 75 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 72 | 0.020 |
Why?
| | Luciferases | 1 | 2009 | 150 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 82 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 219 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1313 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 121 | 0.020 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.020 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 167 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 82 | 0.020 |
Why?
| | Myometrium | 1 | 2008 | 39 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 272 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 164 | 0.020 |
Why?
| | Mice, Nude | 1 | 2009 | 698 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 515 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 437 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1226 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 601 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4565 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 976 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5472 | 0.010 |
Why?
| | Base Sequence | 1 | 2008 | 2181 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 5778 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 13209 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 21513 | 0.010 |
Why?
| | Adult | 1 | 2016 | 37929 | 0.010 |
Why?
|
|
Reno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|